Michael D. Iseman
Impact in
- Small Animals top 0.05%
- Infectious Diseases and Mycology
- Microbiology top 0.2%
Papers in
-
- Tuberculosis Research and Epidemiology 38
- Co-authors
- C. Robert HorsburghGwen A. HuittKevin WinthropCharles L. DaleyAlastair J.J. WoodDavid E. GriffithFred M. GordinAntonino Catanzaro
- Journals
- CHEST Journal (8 papers)Clinical Infectious Diseases (6 papers)American Journal of Respiratory and Critical Care Medicine (6 papers)Clinics in Chest Medicine (3 papers)Annals of Internal Medicine (2 papers)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
Michael D. Iseman
71 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Small Animals 2.4k
- Microbiology 235
- Infectious Diseases 5.8k
- Epidemiology 7.0k
- Surgery 2.4k
Countries citing papers authored by Michael D. Iseman
This map shows the geographic impact of Michael D. Iseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Iseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Iseman more than expected).
Fields of papers citing papers by Michael D. Iseman
This network shows the impact of papers produced by Michael D. Iseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Iseman. The network helps show where Michael D. Iseman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael D. Iseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 6 | |
| 2 | High-Dose Ethambutol: Its Role in Intermittent Chemotherapy | 2015 | 0 |
| 3 | 2013 | 44 | |
| 4 | 2012 | 169 | |
| 5 | 2012 | 5 | |
| 6 | 2011 | 26 | |
| 7 | 2010 | 86 | |
| 8 | 2010 | 101 | |
| 9 | An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Hit paper breakdown → | 2007 | 4257 |
| 10 | The Potential Advantages of Nanoparticle Drug Delivery Systems in Chemotherapy of Tuberculosis Hit paper breakdown → | 2005 | 543 |
| 11 | 2005 | 119 | |
| 12 | 2004 | 254 | |
| 13 | 2001 | 3 | |
| 14 | 1996 | 37 | |
| 15 | 1993 | 1 | |
| 16 | 1993 | 1 | |
| 17 | 1992 | 14 | |
| 18 | 1992 | 4 | |
| 19 | 1987 | 56 | |
| 20 | 1987 | 19 |
About Michael D. Iseman
Michael D. Iseman is a scholar working on Microbiology, Infectious Diseases, Epidemiology, Small Animals and Pharmacology, having authored 72 papers that have together received 9.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (38 papers), Mycobacterium research and diagnosis (35 papers), Infectious Diseases and Tuberculosis (11 papers), Diagnosis and treatment of tuberculosis (8 papers), Quinazolinone synthesis and applications (6 papers), Infectious Diseases and Mycology (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Tracheal and airway disorders (3 papers). The work is most often cited by research in Small Animals (2.4k citations), Microbiology (235 citations), Infectious Diseases (5.8k citations), Epidemiology (7.0k citations) and Surgery (2.4k citations). Michael D. Iseman has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include C. Robert Horsburgh, Gwen A. Huitt, Kevin Winthrop, Charles L. Daley, Alastair J.J. Wood, David E. Griffith, Fred M. Gordin, Antonino Catanzaro, Richard J. Wallace and Timothy R. Aksamit. Their work appears in journals such as CHEST Journal, Clinical Infectious Diseases, American Journal of Respiratory and Critical Care Medicine, Clinics in Chest Medicine and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.